Articles from StarkAge Therapeutics

New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026

PRESS RELEASE

By StarkAge Therapeutics · Via GlobeNewswire · April 16, 2026

StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers

PRESS RELEASE

By StarkAge Therapeutics · Via GlobeNewswire · January 27, 2026